NCT05121441Phase 2Completed

Study to Evaluate ARD-101 in Adults With Obesity

Study sponsor: Aardvark Therapeutics, Inc. · AARD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-11-09Actual
Enrollment · participants20Actual
Source updated2025-01-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.